InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,297.10
(
-0.21%
)
US TECH 100
18,079.20
(
-0.20%
)
Dow Jones
39,869.38
(
-0.10%
)
Brent Oil
83.28
(
0.08%
)
Bitcoin
65,570.03
(
0.51%
)
Post# of 2104
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

JeansOnFire

Send PM Follow Ignore
Followers 9
Posts 381
Boards Moderated 0
Alias Born 06/27/2015

JeansOnFire

Re: Ponch73 post# 1081

Saturday, 01/14/2017 12:58:19 PM

Saturday, January 14, 2017 12:58:19 PM

Post# of 2104
All i know is that the results were good enough for novartis to enter into the license agreement with conatus. It was probably a surprise for conatus too how well emricasan works for high meld score patients. Otherwise there would have been more patients.

Next trials are big enough to make conatus world famous if the results are similar.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM

Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM

Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM

Start posting your company's news
Only $200 per official company press release!